Enhancing the Antitumor Efficacy of Nisin Through Advanced Nanosystems: A Systematic Review of In Vitro Studies
The therapeutic viability of nisin in oncology is strictly dependent on pharmaceutical engineering. Future research must prioritize in vivo pharmacokinetic validation, experimental confirmation of novel mechanistic targets, and standardized nisin purity reporting to consolidate its clinical translation.
Authors
- Jorge Egurrola (ORCID: https://orcid.org/0000-0001-5311-4229)
- Yamil Liscano (ORCID: https://orcid.org/0000-0002-2674-8725)
- Alberto Aragón-Muriel (ORCID: https://orcid.org/0000-0001-5554-9592)
- Sinthia Vidal Cañas
- Mariatta Ceballos Benavides
- Julián Castillo Muñoz (ORCID: https://orcid.org/0009-0009-2772-4360)
- Karol Marcillo Villota
Institutions
- University of Magdalena (CO)
- Universidad Santiago de Cali (CO)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-04-12
- DOI
- https://doi.org/10.3390/ph19040611
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidad del Magdalena